Literature DB >> 3921173

Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalised anxiety.

K G Power, D W Jerrom, R J Simpson, M Mitchell.   

Abstract

A group of patients suffering from anxiety, as assessed by general practitioners and psychologists using research criteria for generalised anxiety, were treated with either diazepam or placebo double blind for six weeks. This active treatment period was preceded by a one week single blind placebo "wash in" period and followed by a two week single blind placebo "wash out" period. The results suggest that diazepam can produce rebound anxiety and withdrawal symptoms when used in moderate doses and for what has previously been regarded as a safe length of time. If replicated these results have implications for the therapeutic use of benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921173      PMCID: PMC1415890          DOI: 10.1136/bmj.290.6477.1246

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  14 in total

1.  Diazepam withdrawal syndrome: a case with psychosis, seizure, and coma.

Authors:  M L de Bard
Journal:  Am J Psychiatry       Date:  1979-01       Impact factor: 18.112

2.  Use of medicines in general practice.

Authors:  D C Skegg; R Doll; J Perry
Journal:  Br Med J       Date:  1977-06-18

3.  A self-rating scale of distress.

Authors:  R Kellner; B F Sheffield
Journal:  Psychol Med       Date:  1973-02       Impact factor: 7.723

Review 4.  [Side effects of benzodiazepines: "rebound" anxiety and insomnia].

Authors:  A Pesce; F Rossi; P Valeri
Journal:  Clin Ter       Date:  1981-12-15

5.  Benzodiazepine withdrawal phenomena.

Authors:  C Hallstrom; M Lader
Journal:  Int Pharmacopsychiatry       Date:  1981

6.  Withdrawal from long-term benzodiazepine treatment.

Authors:  H Petursson; M H Lader
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-05

7.  Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study.

Authors:  A Winokur; K Rickels; D J Greenblatt; P J Snyder; N J Schatz
Journal:  Arch Gen Psychiatry       Date:  1980-01

8.  Single case study. Diazepam (Valium) detoxification.

Authors:  F Miller; J Nulsen
Journal:  J Nerv Ment Dis       Date:  1979-10       Impact factor: 2.254

Review 9.  Benzodiazepine dependence. A review of the evidence.

Authors:  R T Owen; P Tyrer
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

View more
  6 in total

Review 1.  The benzodiazepine withdrawal syndrome and its management.

Authors:  S R Onyett
Journal:  J R Coll Gen Pract       Date:  1989-04

2.  Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate.

Authors:  J S Duncan; S D Shorvon; M R Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

3.  Controlled comparison of pharmacological and psychological treatment of generalized anxiety disorder in primary care.

Authors:  K G Power; R J Simpson; V Swanson; L A Wallace
Journal:  Br J Gen Pract       Date:  1990-07       Impact factor: 5.386

Review 4.  Benzodiazepine dependence. Avoidance and withdrawal.

Authors:  S Marriott; P Tyrer
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

5.  The effects of long-term benzodiazepine treatment and graded withdrawal on psychometric performance.

Authors:  M S Sakol; K G Power
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Differences in health status between long-term and short-term benzodiazepine users.

Authors:  S M Zandstra; J W Furer; E H van de Lisdonk; J H J Bor; F G Zitman; C van Weel
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.